Fu J, Liu B, Liu P, Liu L, Li G, Wu B, Liu X
Health Screen Center of The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):177-81. doi: 10.1055/s-0030-1261965. Epub 2010 Jul 23.
Substance P (SP) is an important neurotransmitter and is an important pathogenic factor in obesity. However, the relationships between the inflammatory cytokines interleukin-6 (IL-6), C reactive protein (CRP) and SP with obesity and type 2 diabetes mellitus (T2DM) are poorly understood.
We investigated the associations between SP, IL-6 and CRP with obesity and T2DM.
The subjects comprised patients who underwent physical examinations at the First Affiliated Hospital of Harbin Medical University between January 2006 and December 2008. Overall, 156 subjects participated in this study, including 63 obese (BMI >25 kg/m²) subjects with T2DM, and 58 obese and 35 lean subjects without T2DM. Patient characteristics were collected from a health questionnaire form. Anthropometric measurements and fasting blood samples were assessed. SP, CRP, IL-6 and HOMA-IR were converted into log values.
SP, IL-6, CRP and HOMA-IR were significantly higher ( P<0.05) in obese T2DM subjects compared with obese and lean subjects without T2DM. All 3 parameters were significantly associated with other risk factors for diabetes, including BMI, blood pressure, plasma glucose and high-density lipoprotein levels. After adjusting for age, SP was significantly and positively correlated with BMI and logHOMA-IR ( P≤0.05); correlation coefficients were higher in obese T2DM subjects than in lean or obese subjects without T2DM.
High levels of SP and IL-6 were significantly associated with obesity and risk factors for T2DM. Associations were of greatest in obese T2DM subjects. Obesity and T2DM show additive effects on the association between SP and BMI or logHOMA-IR.
P物质(SP)是一种重要的神经递质,也是肥胖的一个重要致病因素。然而,炎症细胞因子白细胞介素-6(IL-6)、C反应蛋白(CRP)与SP和肥胖及2型糖尿病(T2DM)之间的关系尚不清楚。
我们研究了SP、IL-6和CRP与肥胖及T2DM之间的关联。
研究对象包括2006年1月至2008年12月在哈尔滨医科大学附属第一医院接受体检的患者。共有156名受试者参与本研究,其中包括63例患有T2DM的肥胖(体重指数>25kg/m²)受试者,以及58例肥胖且无T2DM的受试者和35例非肥胖受试者。从健康调查问卷中收集患者特征。评估人体测量指标和空腹血样。将SP、CRP、IL-6和胰岛素抵抗稳态模型评估(HOMA-IR)转换为对数值。
与无T2DM的肥胖和非肥胖受试者相比,患有T2DM的肥胖受试者的SP、IL-6、CRP和HOMA-IR显著更高(P<0.05)。所有这3项指标均与糖尿病的其他危险因素显著相关,包括体重指数、血压、血糖和高密度脂蛋白水平。在调整年龄后,SP与体重指数和logHOMA-IR显著正相关(P≤0.05);肥胖T2DM受试者的相关系数高于非肥胖或肥胖但无TOD的受试者。
SP和IL-6水平升高与肥胖及T2DM的危险因素显著相关。在肥胖T2DM受试者中这种关联最为明显。肥胖和T2DM对SP与体重指数或logHOMA-IR之间的关联具有叠加效应。